CHICAGO, Sept. 25, 2019 /PRNewswire/ — The Johnson & Johnson Medical Devices Companies* today announced that DePuy Synthes has launched the CONDUIT Interbody Platform with EIT Cellular Titanium Technology, further expanding its comprehensive offering to treat degenerative spine disease. The innovative portfolio, which includes 3D printed titanium interbody implants for spinal fusion surgery is designed to mimic natural …